Classical oxazaphosphorines – metabolism and therapeutic properties – new implications

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Cyclophosphamide (CPA) and ifosfamide (IFO) belong to oxazaphosphorine drugs and for a few decades have been widely used for treatment of solid tumours and haematological malignancies. Both drugs are administered in pharmacologically inactive form and require metabolic activation by cytochrome P-450 (CYP). Metabolic transformations taking place under the action of specific CYP isoenzymes lead to the formation of therapeutically essential metabolites and some toxic compounds affecting quality of therapy. The first stage of these conversions is connected with hydroxylation reactions occurring on the C-4 carbon atom within a ring and C-1 atoms of 2-chloroethyl chains. As a result of C-4 hydroxylation 4-hydroxy derivatives (4-OH-CPA and 4-OH-IFO) are formed and remain in tautomeric equilibrium with aldo compounds which in cancer cells spontaneously release cytotoxic phosphoramide mustards and urotoxic acrolein. At the same time hydroxychloroethyl compounds formed during hydroxylation of side-chains are unstable and collapse with the release of inter alia nephro- and neurotoxic chloroacetaldehyde (CAA). Due to formation of toxic metabolites it is essential to use some preventive agents such as mesna and recently examined agmatine. Since CPA and IFO are widely used anticancer drugs, their efficacy is limited not only by their toxicity but also due to occurring resistance. This resistance seems to be a result of changes of expression and activity of enzymes such as CYP and aldehyde dehydrogenase (ALDH) and increase of intracellular levels of glutathione (GSH) and glutathione S-transferase (GST). At present a few methods of overcoming this resistance are being examined including the use of metabolism modulators, antisense oligonucleotides selectively inhibiting gene expression, and introducing genes of some CYP isoenzymes to a cancer tissue.

Authors and Affiliations

Anna Sloderbach, Agnieszka Górska, Marta Sikorska, Konrad Misiura, Bogusław Hładoń

Keywords

Related Articles

Hereditary prostate cancer

Prostate cancer (PC) is one of the most common cancers affecting men. It may soon become the main cancer - caused mortality among men all over the world. The genetic basis of prostate cancer is very complex and its etiol...

The clinical significance of fatty acid binding proteins

Excessive levels of free fatty acids are toxic to cells. The human body has evolved a defense mechanism in the form of small cytoplasmic proteins called fatty acid binding proteins (FABPs) that bind long-chain fatty acid...

Vaccines in prophylaxis of urinary tract infections caused by the bacteria from the genus Proteus

Urinary tract infections (UTIs) pose a threat especially to women, the individuals with weakened immunity or with abnormalities in the urinary tract as well as to hospitalized and catheterized patients. The bacteria from...

Preliminary study on application of urine amino acids profiling for monitoring of renal tubular injury using GLC-MS

The early diagnosis of the nephrotoxic effect of xenobiotics and drugs is still an unsolved problem. Recent studies suggest a correlation between the nephrotoxic activity of xenobiotics and increased concentration of ami...

Download PDF file
  • EP ID EP67221
  • DOI -
  • Views 138
  • Downloads 0

How To Cite

Anna Sloderbach, Agnieszka Górska, Marta Sikorska, Konrad Misiura, Bogusław Hładoń (2013). Classical oxazaphosphorines – metabolism and therapeutic properties – new implications. Advances in Hygiene and Experimental Medicine, 67(0), 1235-1253. https://europub.co.uk/articles/-A-67221